Day: November 19, 2024

Medera and Singapore’s Cardiovascular Disease National Collaborative Enterprise Launch Asia’s First Cardiac Gene Therapy Trial for Heart Failure

Medera and Cardiovascular Disease National Collaborative Enterprise (CADENCE) announce the initiation of Asia's first cardiac gene therapy clinical trial for...

error: Content is protected !!